Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription


1 Acta Biochim Biophys Sin (Shanghai)
1 Adv Radiat Oncol
1 AIDS Care
1 Am J Clin Oncol
1 Am J Surg Pathol
1 Ann Pharm Fr
1 Ann Surg Oncol
1 Anticancer Agents Med Chem
1 Apoptosis
1 Biology (Basel)
1 Biomolecules
2 BMC Womens Health
2 BMJ Open
1 Cancer Control
2 Cancer Epidemiol
1 Cancer Lett
2 Cancer Med
1 Cancer Radiother
2 Cancers (Basel)
1 Cell Death Dis
1 Chem Biol Interact
1 Clin Cancer Res
1 Clin Transl Oncol
1 Cochrane Database Syst Rev
1 Community Health Equity Res Policy
1 Comput Biol Med
3 Contrast Media Mol Imaging
1 Curr Oncol
1 Cytotechnology
1 Drug Des Devel Ther
2 Epidemiol Health
1 ESMO Open
1 Eur J Cancer Prev
1 Eur J Investig Health Psychol Educ
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Radiol
1 Exp Cell Res
1 Front Cell Infect Microbiol
1 Front Glob Womens Health
3 Front Oncol
1 Gynecol Oncol Rep
2 Healthcare (Basel)
1 Infect Agent Cancer
1 Insights Imaging
1 Int J Appl Basic Med Res
1 Int J Environ Res Public Health
2 Int J Gynecol Cancer
1 Int Wound J
1 J Community Health
2 J Gen Intern Med
1 J Gynecol Obstet Hum Reprod
1 J Immunother Cancer
1 J Infect Dis
1 J Inflamm Res
1 J Lab Physicians
4 J Low Genit Tract Dis
1 J Med Virol
1 J Obstet Gynaecol Res
1 J Pers Med
2 J Radiat Res
1 J Transl Med
1 JAMA Oncol
1 JMIR Public Health Surveill
1 Lancet Glob Health
1 Med J Islam Repub Iran
1 Med Sci (Basel)
1 Medicina (Kaunas)
1 Medicine (Baltimore)
1 Microorganisms
1 Nanoscale Adv
1 Obstet Gynecol Clin North Am
1 Obstet Gynecol Int
1 Oncol Rep
1 Pathogens
1 Pathol Oncol Res
1 Pediatr Surg Int
5 PLoS One
1 Prev Chronic Dis
1 Prev Med
1 Public Health Pract (Oxf)
1 Radiother Oncol
1 Rev Epidemiol Sante Publique
1 Salud Publica Mex
3 Sci Rep
1 Soc Sci Med
1 Strahlenther Onkol
1 Transl Oncol
1 Tumori
1 Vaccine
1 Vaccines (Basel)
1 Virology
1 Womens Health Rep (New Rochelle)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Biochim Biophys Sin (Shanghai)

  1. XU H, Liu M, Song Y, Liu L, et al
    Metabolomics variation profiling of vaginal discharge identifies potential targets for cervical cancer early warning.
    Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25. doi: 10.3724/abbs.2022133.

    Adv Radiat Oncol

  2. WASHINGTON B, Randall M, Fabian D, Cheek D, et al
    Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy.
    Adv Radiat Oncol. 2022;7:101019.
    PubMed         Abstract available

    AIDS Care

  3. CHINCHA LINO OJ, Chinchihualpa Paredes NO, Samalvides Cuba F
    Factors associated with normal or abnormal Papanicolaou smear among HIV-infected women at a national hospital in Lima, Peru, 2012-2015.
    AIDS Care. 2022;34:1264-1267.
    PubMed         Abstract available

    Am J Clin Oncol

  4. ALIMENA S, Davis M, Pelletier A, Terry K, et al
    Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients.
    Am J Clin Oncol. 2022;45:415-421.
    PubMed         Abstract available

    Am J Surg Pathol

  5. COSTIGAN DC, Nucci MR, Dickson BC, Chang MC, et al
    NTRK-Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Am J Surg Pathol. 2022 Jun 20. pii: 00000478-990000000-00034.
    PubMed         Abstract available

    Ann Pharm Fr

  6. BARAQUIN A, Pepin L, Floerchinger P, Lepiller Q, et al
    [New recommendations for cervical cancer screening in France].
    Ann Pharm Fr. 2022 Sep 20. pii: S0003-4509(22)00120.
    PubMed         Abstract available

    Ann Surg Oncol

  7. RONSINI C, Solazzo MC, Bizzarri N, Ambrosio D, et al
    ASO Author Reflections: Fertility-Sparing Treatment for Early-Stage Cervical Cancer 2 cm or Larger in Size: A Problem Still Open.
    Ann Surg Oncol. 2022 Sep 15. pii: 10.1245/s10434-022-12556.

    Anticancer Agents Med Chem

  8. EREN CY, Gurer HG, Gursoy OO, Sezer CV, et al
    Antitumor Effects of L-citrulline on Hela Cervical Cancer Cell Lines.
    Anticancer Agents Med Chem. 2022;22:3157-3162.
    PubMed         Abstract available


  9. LU M, Gao Q, Wang Y, Ren J, et al
    LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis.
    Apoptosis. 2022 Sep 14. pii: 10.1007/s10495-022-01768.
    PubMed         Abstract available

    Biology (Basel)

  10. VOIDAZAN ST, Dianzani C, Husariu MA, Gered B, et al
    The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review.
    Biology (Basel). 2022;11.
    PubMed         Abstract available


  11. YEKEHFALLAH V, Pahlavanneshan S, Sayadmanesh A, Momtahan Z, et al
    Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells.
    Biomolecules. 2022;12.
    PubMed         Abstract available

    BMC Womens Health

  12. MONTI E, Barbara G, Libutti G, Boero V, et al
    A clinician's dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?
    BMC Womens Health. 2022;22:379.
    PubMed         Abstract available

  13. GUO C, Tao X, Zhang L, Zhang Y, et al
    A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma patients.
    BMC Womens Health. 2022;22:377.
    PubMed         Abstract available

    BMJ Open

  14. LOKKE KF, Rasch V, Mwaiselage J, Gammeltoft T, et al
    Acceptability of text messages and knowledge change for cervical cancer screening: a Tanzanian mixed methods study.
    BMJ Open. 2022;12:e058450.
    PubMed         Abstract available

  15. YANG S, Bai L, Xu W, Zhang R, et al
    Profiling the real-world management status of high-risk human papillomavirus infection: a protocol to establish a prospective cohort of high-risk human papillomavirus-infected women in Lueyang County, China.
    BMJ Open. 2022;12:e062678.
    PubMed         Abstract available

    Cancer Control

  16. GEBREKIRSTOS LG, Gebremedhin MH, Tafesse TT, Tura TS, et al
    Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
    Cancer Control. 2022;29:10732748221126944.
    PubMed         Abstract available

    Cancer Epidemiol

  17. CHATURVEDI M, Sathishkumar K, Lakshminarayana SK, Nath A, et al
    Women cancers in India: Incidence, trends and their clinical extent from the National Cancer Registry Programme.
    Cancer Epidemiol. 2022;80:102248.
    PubMed         Abstract available

  18. SI J, Wang P, Zheng Y, Xue Q, et al
    Cancer incidence and spectrum among Uygurs in Hotan District in China.
    Cancer Epidemiol. 2022;80:102217.
    PubMed         Abstract available

    Cancer Lett

  19. ZHANG YR, Zheng PS
    NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes.
    Cancer Lett. 2022 Sep 14:215917. doi: 10.1016/j.canlet.2022.215917.
    PubMed         Abstract available

    Cancer Med

  20. CHAO CR, Chubak J, Beaber EF, Kamineni A, et al
    Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings.
    Cancer Med. 2022 Sep 15. doi: 10.1002/cam4.5226.
    PubMed         Abstract available

  21. ILIC I, Babic G, Dimitrijevic A, Grujicic SS, et al
    Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test.
    Cancer Med. 2022;11:3518-3528.
    PubMed         Abstract available

    Cancer Radiother

  22. LUCIA F, Miranda O, Schick U, Bourbonne V, et al
    Dose escalation by brachytherapy for gynecological cancers.
    Cancer Radiother. 2022;26.
    PubMed         Abstract available

    Cancers (Basel)

  23. KONDO E, Yoshida K, Kubo-Kaneda M, Nii M, et al
    Does Vaginal Cuff Creation and Avoidance of a Uterine Manipulator Improve the Prognosis of Total Laparoscopic Radical Hysterectomy for Early Cervical Cancer? A Retrospective Multicenter Study.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available

  24. GILL R, Abdah-Bortnyak R, Amit A, Bar-Peled U, et al
    [F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available

    Cell Death Dis

  25. LIN M, Zhang J, Bouamar H, Wang Z, et al
    Fbxo22 promotes cervical cancer progression via targeting p57(Kip2) for ubiquitination and degradation.
    Cell Death Dis. 2022;13:805.
    PubMed         Abstract available

    Chem Biol Interact

  26. QI L, Wang Y, Su S, Wang M, et al
    Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a /GADD45a axis.
    Chem Biol Interact. 2022;367:110171.
    PubMed         Abstract available

    Clin Cancer Res

  27. AN J, Tang J, Li BX, Xiong H, et al
    Efficacy and Safety of the Anti-PD-L1 Monoclonal Antibody Socazolimab for Recurrent or Metastatic Cervical Cancer: A Phase I Dose-Escalation and Expansion Study.
    Clin Cancer Res. 2022 Sep 22. pii: 709354. doi: 10.1158/1078-0432.CCR-22-1280.
    PubMed         Abstract available

    Clin Transl Oncol

  28. WANG Y, Lai Y, Peng H, Yan S, et al
    Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.
    Clin Transl Oncol. 2022 Sep 17. pii: 10.1007/s12094-022-02945.
    PubMed         Abstract available

    Cochrane Database Syst Rev

  29. CHAKRABARTI M, Nordin A, Khodabocus J
    Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
    Cochrane Database Syst Rev. 2022;9:CD012246.
    PubMed         Abstract available

    Community Health Equity Res Policy

  30. CHRISTENSEN K, Bauer AG, Burgin T, Williams J, et al
    "Black Women Don't Always Put Our Healthcare First": Facilitators and Barriers to Cervical Cancer Screening and Perceptions of Human Papillomavirus Self-Testing Among Church-Affiliated African American Women.
    Community Health Equity Res Policy. 2022 Sep 20:272684X221115494.
    PubMed         Abstract available

    Comput Biol Med

  31. VAGHASIA H, Sakaria S, Prajapati J, Saraf M, et al
    Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
    Comput Biol Med. 2022;149:105994.
    PubMed         Abstract available

    Contrast Media Mol Imaging

  32. RAMESH K, Agarwal P, Ahuja V, Mir BA, et al
    Biomedical Application of Identified Biomarkers Gene Expression Based Early Diagnosis and Detection in Cervical Cancer with Modified Probabilistic Neural Network.
    Contrast Media Mol Imaging. 2022;2022:4946154.
    PubMed         Abstract available

  33. HAN Y, Li Q, Ling C, Jin M, et al
    HPV-Induced MiR-21 Promotes Epithelial Mesenchymal Transformation and Tumor Progression in Cervical Cancer Cells through the TGFbeta R2/hTERC Pathway.
    Contrast Media Mol Imaging. 2022;2022:6297694.
    PubMed         Abstract available

  34. ZHOU Y
    Investigation of the Clinical Application Value of HR-HPV DNA Combined with Liquid Based Cytology in Colposcopy of Cervical Cancer.
    Contrast Media Mol Imaging. 2022;2022:5054507.
    PubMed         Abstract available

    Curr Oncol

  35. CUI Z, Kawasaki H, Tsunematsu M, Cui Y, et al
    Factors Affecting the Cervical Cancer Screening Behaviors of Japanese Women in Their 20s and 30s Using a Health Belief Model: A Cross-Sectional Study.
    Curr Oncol. 2022;29:6287-6302.
    PubMed         Abstract available


  36. HONGWEI L, Juan L, Xiaoying X, Zhijun F, et al
    MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.
    Cytotechnology. 2022;74:469-478.
    PubMed         Abstract available

    Drug Des Devel Ther

  37. GE Y, Zhang Y, Zhao KN, Zhu H, et al
    Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer.
    Drug Des Devel Ther. 2022;16:3055-3070.
    PubMed         Abstract available

    Epidemiol Health

  38. LUU XQ, Lee K, Jun JK, Suh M, et al
    Effect of Pap Smear on the Long-term Survival of Cervical Cancer Patients: A Nationwide Population-based Cohort Study.
    Epidemiol Health. 2022 Sep 7:e2022072. doi: 10.4178/epih.e2022072.
    PubMed         Abstract available

  39. TRINH TTK, Lee YY, Suh M, Jun JK, et al
    Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
    Epidemiol Health. 2022;44:e2022051.
    PubMed         Abstract available

    ESMO Open

  40. GENNIGENS C, Jerusalem G, Lapaille L, De Cuypere M, et al
    Recurrent or primary metastatic cervical cancer: current and future treatments.
    ESMO Open. 2022;7:100579.
    PubMed         Abstract available

    Eur J Cancer Prev

  41. DESIMPEL F, Declercq S, Makar A
    Cervical cancer screening and outcomes for women under 25 years of age in Belgium: a 10-year nationwide study.
    Eur J Cancer Prev. 2022 Sep 12. pii: 00008469-990000000-00024.
    PubMed         Abstract available

    Eur J Investig Health Psychol Educ

  42. GUTIERREZ-ENRIQUEZ SO, Guerrero-Zacarias MC, Oros-Ovalle C, Teran-Figueroa Y, et al
    Computer System for the Capture and Preparation of Cytopathological Reports for Cervical Cancer Detection and His Utility in Training for Health Personnel.
    Eur J Investig Health Psychol Educ. 2022;12:1323-1333.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  43. BOGANI G, Di Donato V, Muzii L, Casarin J, et al
    Corrigendum to "Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer" [Eur. J. Obstet. Gynecol. 275 (2022) 64-69].
    Eur J Obstet Gynecol Reprod Biol. 2022;278:66.

    Eur J Radiol

  44. REN J, Li Y, Liu XY, Zhao J, et al
    Diagnostic performance of ADC values and MRI-based radiomics analysis for detecting lymph node metastasis in patients with cervical cancer: A systematic review and meta-analysis.
    Eur J Radiol. 2022;156:110504.
    PubMed         Abstract available

    Exp Cell Res

  45. GAO F, Chen J, Zhang T, Liu N, et al
    LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
    Exp Cell Res. 2022 Sep 16:113360. doi: 10.1016/j.yexcr.2022.113360.
    PubMed         Abstract available

    Front Cell Infect Microbiol

  46. ZHANG J, Yang D, Cui X, Liu G, et al
    Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China.
    Front Cell Infect Microbiol. 2022;12:935071.
    PubMed         Abstract available

    Front Glob Womens Health

  47. DESTA AA, Alemu FT, Gudeta MB, Dirirsa DE, et al
    Willingness to utilize cervical cancer screening among Ethiopian women aged 30-65 years.
    Front Glob Womens Health. 2022;3:939639.
    PubMed         Abstract available

    Front Oncol

  48. WANG M, Ma M, Yang L, Liang C, et al
    Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer.
    Front Oncol. 2022;12:952347.
    PubMed         Abstract available

  49. ZHANG Z, Zhang S, Lin B, Wang Q, et al
    Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo.
    Front Oncol. 2022;12:974573.
    PubMed         Abstract available

  50. LI Z, Chen K, Yang Z, Zhu Q, et al
    A personalized DVH prediction model for HDR brachytherapy in cervical cancer treatment.
    Front Oncol. 2022;12:967436.
    PubMed         Abstract available

    Gynecol Oncol Rep

  51. ISONO-TANIGUCHI R, Goto M, Takimoto Y, Ueda T, et al
    Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study.
    Gynecol Oncol Rep. 2022;42:101013.
    PubMed         Abstract available

    Healthcare (Basel)

  52. VEGA CRESPO B, Neira VA, Ortiz S J, Maldonado-Rengel R, et al
    Evaluation of Urine and Vaginal Self-Sampling versus Clinician-Based Sampling for Cervical Cancer Screening: A Field Comparison of the Acceptability of Three Sampling Tests in a Rural Community of Cuenca, Ecuador.
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

  53. BENSEMMANE S, Loayza Villarroel K, Montano K, Louati E, et al
    Assessing Barriers Encountered by Women in Cervical Cancer Screening and Follow-Up Care in Urban Bolivia, Cochabamba.
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

    Infect Agent Cancer

  54. HAGHIGHI D, Yazdani S, Farzanehpour M, Esmaeili Gouvarchinghaleh H, et al
    Combined extract of heated TC1, a heat-killed preparation of Lactobacillus casei and alpha-galactosyl ceramide in a mouse model of cervical cancer.
    Infect Agent Cancer. 2022;17:51.
    PubMed         Abstract available

    Insights Imaging

  55. SONG Q, Pang H, Tong R, Zhu Y, et al
    MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results.
    Insights Imaging. 2022;13:148.
    PubMed         Abstract available

    Int J Appl Basic Med Res

  56. RAMYA C, Inuganti RV, Vaddatti T, Shaik N, et al
    Actinomycosis of the Cervix Mimicking Stage II Cervical Cancer.
    Int J Appl Basic Med Res. 2022;12:214-216.
    PubMed         Abstract available

    Int J Environ Res Public Health

  57. BOGANI G, Di Donato V, Scambia G, Raspagliesi F, et al
    Radical Hysterectomy for Early Stage Cervical Cancer.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

    Int J Gynecol Cancer

  58. CAPISTRANO I R, Paul S, Boere I, Pantziarka P, et al
    Drug repurposing as a potential source of innovative therapies in cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 22. pii: ijgc-2022-003585.
    PubMed         Abstract available

  59. MARTINEZ A, Diaz-Feijoo B, Querleu D
    Para-aortic lymphadenectomy in cervical cancer deserves a new trial.
    Int J Gynecol Cancer. 2022 Sep 16. pii: ijgc-2022-003910.

    Int Wound J

  60. ZHENG S, Liu X, Cheng L, Wu Q, et al
    Effect of minimally invasive surgery and laparotomy on wound infection and postoperative and intraoperative complications in the management of cervical cancer: A meta-analysis.
    Int Wound J. 2022 Sep 16. doi: 10.1111/iwj.13962.
    PubMed         Abstract available

    J Community Health

  61. WILSON PA, Sack DE, Gonzalez Pena T, Lloyd MC, et al
    A Cross-Sectional Study of Disparities in Screening Guideline Concordance Within a Student-Run Clinic.
    J Community Health. 2022;47:759-764.
    PubMed         Abstract available

    J Gen Intern Med

  62. KEDDEM S, Maier M, Gardella C, Borgerding J, et al
    Gonorrhea and Chlamydia Testing and Case Rates Among Women Veterans in the Veterans Health Administration.
    J Gen Intern Med. 2022;37.
    PubMed         Abstract available

  63. CALLEGARI LS, Mahorter SS, Benson SK, Zhao X, et al
    Perceived Contraceptive Counseling Quality Among Veterans Using VA Primary Care: Data from the ECUUN Study.
    J Gen Intern Med. 2022;37.
    PubMed         Abstract available

    J Gynecol Obstet Hum Reprod

  64. NOURRISSON A, Lepetit H, Marty M, Garrigue I, et al
    Regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) managed expectantly.
    J Gynecol Obstet Hum Reprod. 2022;51:102442.
    PubMed         Abstract available

    J Immunother Cancer

  65. NI H, Zhang H, Li L, Huang H, et al
    T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    J Immunother Cancer. 2022;10.
    PubMed         Abstract available

    J Infect Dis

  66. ANDRADE PESSOA MORALES J, Marconi C, El-Zein M, Ravel J, et al
    Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection.
    J Infect Dis. 2022;226:1084-1097.
    PubMed         Abstract available

    J Inflamm Res

  67. JIANG P, Kong W, Gong C, Chen Y, et al
    Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.
    J Inflamm Res. 2022;15:5265-5281.
    PubMed         Abstract available

    J Lab Physicians

  68. SHARMA B, Lakhanpal V, Singh K, Oberoi L, et al
    Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.
    J Lab Physicians. 2022;14:336-342.
    PubMed         Abstract available

    J Low Genit Tract Dis

  69. BRUHN LV, Hyldig N, Schledermann D
    HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study.
    J Low Genit Tract Dis. 2022;26:287-292.
    PubMed         Abstract available

  70. WANG SM, Hoeppner C, Kazma J, Keegan E, et al
    Diagnostic Utility of Endocervical Curettage During Colposcopy Among Patients of Varying Risk Factors.
    J Low Genit Tract Dis. 2022;26:298-303.
    PubMed         Abstract available

  71. TZUR Y, Berkovitz-Shperling R, Laskov I, Grisaru D, et al
    Recurrent Dysplasia After a Loop Electrosurgical Excision Procedure: Local Versus General Anesthesia.
    J Low Genit Tract Dis. 2022;26:315-318.
    PubMed         Abstract available

  72. MONTI E, Somigliana E, Alberico D, Boero V, et al
    Conservative Treatment for Cervical Adenocarcinoma In Situ: Long-Term Results.
    J Low Genit Tract Dis. 2022;26:293-297.
    PubMed         Abstract available

    J Med Virol

  73. ZHEN S, Qiang R, Lu J, Tuo X, et al
    CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection associated cervical cancer.
    J Med Virol. 2022 Sep 19. doi: 10.1002/jmv.28144.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  74. YAN X, Qu Y, Huang W, Zhang H, et al
    Identification and construction of a prognostic risk model based on multi-RNA methylation regulators in cervical cancer.
    J Obstet Gynaecol Res. 2022 Sep 13. doi: 10.1111/jog.15421.
    PubMed         Abstract available

    J Pers Med

  75. DELLINO M, Cascardi E, Tomasone V, Zaccaro R, et al
    Communications Is Time for Care: An Italian Monocentric Survey on Human Papillomavirus (HPV) Risk Information as Part of Cervical Cancer Screening.
    J Pers Med. 2022;12.
    PubMed         Abstract available

    J Radiat Res

  76. WATANABE Y, Maeyama T, Mizukami S, Tachibana H, et al
    Verification of dose distribution in high dose-rate brachytherapy for cervical cancer using a normoxic N-vinylpyrrolidone polymer gel dosimeter.
    J Radiat Res. 2022 Sep 16. pii: 6701778. doi: 10.1093.
    PubMed         Abstract available

  77. YOSHIO K, Ihara H, Okamoto K, Suzuki E, et al
    Tumor size before image-guided brachytherapy is an important factor of local control after radiotherapy for cervical squamous cell carcinoma: analysis in cases using central shielding.
    J Radiat Res. 2022;63:772-779.
    PubMed         Abstract available

    J Transl Med

  78. ARBYN M, Bonde J, Cushieri K, Poljak M, et al
    Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
    J Transl Med. 2022;20:422.

    JAMA Oncol

  79. TEGLIA F, Angelini M, Astolfi L, Casolari G, et al
    Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis.
    JAMA Oncol. 2022;8:1287-1293.
    PubMed         Abstract available

    JMIR Public Health Surveill

  80. JO S, Pituch KA, Howe N
    The Relationships Between Social Media and Human Papillomavirus Awareness and Knowledge: Cross-sectional Study.
    JMIR Public Health Surveill. 2022;8:e37274.
    PubMed         Abstract available

    Lancet Glob Health

  81. TRIMBLE CL, Trimble EL
    HPV vaccines: when one plus one equals three.
    Lancet Glob Health. 2022;10:e1373-e1374.

    Med J Islam Repub Iran

  82. SHOKRI JAMNANI ASJ, Rezapour A, Moradi N, Langarizadeh M, et al
    Women's Preference for Cervical Cancer Screening Methods in Iran: A Contingent Valuation Survey.
    Med J Islam Repub Iran. 2022;36:72.
    PubMed         Abstract available

    Med Sci (Basel)

  83. MORALES CG, Jimenez NR, Herbst-Kralovetz MM, Lee NR, et al
    Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women.
    Med Sci (Basel). 2022;10.
    PubMed         Abstract available

    Medicina (Kaunas)

  84. TRAMACERE F, Lancellotta V, Casa C, Fionda B, et al
    Assessment of Sexual Dysfunction in Cervical Cancer Patients after Different Treatment Modality: A Systematic Review.
    Medicina (Kaunas). 2022;58.
    PubMed         Abstract available

    Medicine (Baltimore)

  85. ZHOU J, Wei XC, Xu HY, Hu HB, et al
    Blood glucose levels and the risk of HPV multiple infections in high-grade squamous intraepithelial lesions: A retrospective cross-sectional study of Chinese patients.
    Medicine (Baltimore). 2022;101:e30494.
    PubMed         Abstract available


  86. BASERA A, Hull R, Demetriou D, Bates DO, et al
    Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities.
    Microorganisms. 2022;10.
    PubMed         Abstract available

    Nanoscale Adv

  87. DU Z, Ma R, Chen S, Fan H, et al
    A highly efficient polydopamine encapsulated clinical ICG theranostic nanoplatform for enhanced photothermal therapy of cervical cancer.
    Nanoscale Adv. 2022;4:4016-4024.
    PubMed         Abstract available

    Obstet Gynecol Clin North Am

  88. HUTCHCRAFT ML, Miller RW
    Bleeding from Gynecologic Malignancies.
    Obstet Gynecol Clin North Am. 2022;49:607-622.
    PubMed         Abstract available

    Obstet Gynecol Int

  89. ATJIMAKUL T, Hanprasertpong J
    Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence.
    Obstet Gynecol Int. 2022;2022:3446293.
    PubMed         Abstract available

    Oncol Rep

  90. RAMLI I, Susworo S, Nuranna L, Mansyur M, et al
    Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested casecontrol study.
    Oncol Rep. 2022;48.
    PubMed         Abstract available


  91. MONTEIRO JC, Tsutsumi MY, de Carvalho DO, da Silva Costa EDC, et al
    Prevalence, Diversity, and Risk Factors for Cervical HPV Infection in Women Screened for Cervical Cancer in Belem, Para, Northern Brazil.
    Pathogens. 2022;11.
    PubMed         Abstract available

    Pathol Oncol Res

  92. ZHOU L, Wu H, Bai X, Min S, et al
    O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer.
    Pathol Oncol Res. 2022;28:1610554.
    PubMed         Abstract available

    Pediatr Surg Int

  93. WEHRLI LA, Bischoff A, De La Torre L, Reppucci ML, et al
    Pelvic exams and cervical cancer screening in patients with anorectal malformations.
    Pediatr Surg Int. 2022 Sep 15. pii: 10.1007/s00383-022-05218.
    PubMed         Abstract available

    PLoS One

  94. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    PubMed         Abstract available

  95. ZIBAKO P, Tsikai N, Manyame S, Ginindza TG, et al
    Cervical cancer management in Zimbabwe (2019-2020).
    PLoS One. 2022;17:e0274884.
    PubMed         Abstract available

  96. DAI L, Mugaanyi J, Zhang T, Tong J, et al
    A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.
    PLoS One. 2022;17:e0274823.
    PubMed         Abstract available

  97. ABAS BI, Demirbolat GM, Cevik O
    Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel.
    PLoS One. 2022;17:e0274607.
    PubMed         Abstract available

    Individual and intimate-partner factors associated with cervical cancer screening in Central Uganda.
    PLoS One. 2022;17:e0274602.
    PubMed         Abstract available

    Prev Chronic Dis

  99. BERMUDEZ Y, Scott LC, Beckman M, DeGroff A, et al
    Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program.
    Prev Chronic Dis. 2022;19:E59.
    PubMed         Abstract available

    Prev Med

  100. FERRARA P, Dallagiacoma G, Alberti F, Gentile L, et al
    Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.
    Prev Med. 2022 Sep 20:107264. doi: 10.1016/j.ypmed.2022.107264.
    PubMed         Abstract available

    Public Health Pract (Oxf)

  101. OSEI EA, Ani-Amponsah M
    Ghanaian women's perception on cervical cancer threat, severity, and the screening benefits: A qualitative study at Shai Osudoku District, Ghana.
    Public Health Pract (Oxf). 2022;3:100274.
    PubMed         Abstract available

    Radiother Oncol

  102. SKIPAR K, Hompland T, Vassmo Lund K, Londalen A, et al
    Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.
    Radiother Oncol. 2022 Sep 13. pii: S0167-8140(22)04266.
    PubMed         Abstract available

    Rev Epidemiol Sante Publique

  103. ARECHKIK A, Lahlou L, Obtel M, Kharbach A, et al
    Cervical cancer in Morocco: A systematic review.
    Rev Epidemiol Sante Publique. 2022;70:230-242.
    PubMed         Abstract available

    Salud Publica Mex

  104. FERNANDEZ-DEAZA G, Caicedo-Martinez M, Serrano B, Roura E, et al
    Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges.
    Salud Publica Mex. 2022;64.
    PubMed         Abstract available

    Sci Rep

  105. GRINCEVICIENE S, Vaitkiene D, Kanopiene D, Vanseviciute R, et al
    Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia.
    Sci Rep. 2022;12:15397.
    PubMed         Abstract available

  106. HAGIYA H, Koyama T, Otsuka F
    Impact of the cervical cancer awareness months on public interest in Japan: A Google Trends analysis, 2012-2021.
    Sci Rep. 2022;12:15391.
    PubMed         Abstract available

  107. TIEN CT, Li PC, Chen CJ, Ding DC, et al
    Clinical characteristics and a 2-year follow-up of unsatisfactory conventional Pap smears: a retrospective case-control study.
    Sci Rep. 2022;12:15393.
    PubMed         Abstract available

    Soc Sci Med

  108. QUINTAL C, Antunes M
    Mirror, mirror on the wall, when are inequalities higher, after all? Analysis of breast and cervical cancer screening in 30 European countries.
    Soc Sci Med. 2022;312:115371.
    PubMed         Abstract available

    Strahlenther Onkol

  109. KE T, Wang J, Zhang N, Zhao H, et al
    Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
    Strahlenther Onkol. 2022 Sep 15. pii: 10.1007/s00066-022-02000.
    PubMed         Abstract available

    Transl Oncol

  110. TAN S, Chen Y, Du S, Li W, et al
    TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells.
    Transl Oncol. 2022;26:101539.
    PubMed         Abstract available


  111. ADORNI M, Bazzurini L, Lissoni AA, Vecchione F, et al
    Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
    Tumori. 2022;108:495-501.
    PubMed         Abstract available


  112. PRUDDEN HJ, Achilles SL, Schocken C, Broutet N, et al
    Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)00999.
    PubMed         Abstract available

    Vaccines (Basel)

  113. BENCHERIT D, Kidar R, Otmani S, Sallam M, et al
    Knowledge and Awareness of Algerian Students about Cervical Cancer, HPV and HPV Vaccines: A Cross-Sectional Study.
    Vaccines (Basel). 2022;10.
    PubMed         Abstract available


  114. OLCZAK P, Wong M, Tsai HL, Wang H, et al
    Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.
    Virology. 2022;575:63-73.
    PubMed         Abstract available

    Womens Health Rep (New Rochelle)

  115. SCHRIER E, Holt HK, Kuppermann M, Sawaya GF, et al
    Changing Preferences for a Cervical Cancer Screening Strategy: Moving Away from Annual Testing.
    Womens Health Rep (New Rochelle). 2022;3:709-717.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.